Statin Short-term Inhibition of Insulin Sensitivity and Secretion During Acute Phase of ST-Elevation Myocardial Infarction.

ABSTRACT: Hyperglycemia during myocardial infarction (MI) has a strong and direct association with mortality. In stable patients and experimental models, statins favor the elevation of glycaemia. The present study investigated whether short-course treatment with statins during MI can influence glucose homeostasis and thus the clinical outcome. In this prospective study, euglycemic hyperinsulinemic clamp (EHC) was performed at second (D2) and sixth (D6) day after MI in patients randomized to simvastatin (S)10 or 80?mg/day during hospitalization (n?=?27). In addition, patients (n?=?550) were treated without (WS) or with simvastatin (S) at 20, 40 or 80?mg/day had HOMA2S on admission (D1) and fifth (D5) day after MI. According to EHC, insulin sensitivity increased by 20?±?60% in S10 and decreased by -6?±?28% in S80 (p?=?0.025). Consistently, the changes in HOMA2S between D1 and D5 were 40?±?145% (WS), 22?±?117% (S20), 16?±?61% (S40) and -2%?±?88% (S80) (p?=?0.001). In conclusion, statin during the acute phase of MI reduces insulin sensitivity in a dose-dependent manner.

SUBMITTER: Sposito AC 

PROVIDER: S-EPMC6841947 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature